|
| Association found | No association found |
|
| Age | Liu et al. [4] (lower NLR in patients < 45 years)
Lang et al. [6] (lower NLR in patients < 45 years)
Kim et al. [15] (lower NLR in patients ≥ 45 years) | Liu et al. [3]
Kim et al. [5]
Gong et al. [14]
Manatakis et al. |
|
| Sex | | Liu et al. [3], Liu et al. [4], Kim et al. [5],
Lang et al. [6], Gong et al. [14]
Manatakis et al. |
|
| Tumour size | Liu et al. [3], Kim et al. [5],
Lang et al. [6], Gong et al. [14] | Liu et al. [4], Cho et al. [8],
Kim et al. [15], Manatakis et al. |
|
| Extrathyroidal invasion | Manatakis et al. | Liu et al. [3], Liu [4] Kim et al. [5],
Lang et al. [6], Kim et al. [15] |
|
| Multifocality | Gong et al. [14], Manatakis et al. | Liu et al. [3], Kim et al. [5], Lang et al. [6],
Kim et al. [15] |
|
| Bilaterality | Manatakis et al. | Lang et al. [6] |
|
| Lymphovascular invasion | | Liu et al. [3], Lang et al. [6], Kim et al. [15] |
|
| Lymph node metastasis | Gong et al. [14], Manatakis et al. | Liu et al. [3], Liu et al. [4], Kim et al. [5],
Lang et al. [6], Kim et al. [15] |
|
| TNM stage | Liu et al. [4] (stages I-II versus III-IV)
Lang et al. [6] (for stage I)
Gong et al. [14] (for patients ≥ 45 years) | Liu et al. [3]
Kim et al. [5]
Kim et al. [15]
Manatakis et al. |
|
| Histologic subtype | | Lang et al. [6], Manatakis et al. |
|
| Thyroiditis | Kim et al. [15] (lower NLR in Hashimoto) | Liu et al. [3], Lang et al. [6],
Kocer et al. [16], Manatakis et al. |
|
| Recurrence risk | Liu et al. [3] | |
|
| Prognosis | Kim et al. [5] (for stages III-IV) | Lang et al. [6], Cho et al. [8] |
|
